Trastuzumab 5 mg
Trastuzumab (CAS 180288-69-1) is a kinase inhibitor research compound from TOKU-E, supplied as 5 mg. Purity ≥97%. Typical use: cancer research. Store at -20 °C.
| CAS number | 180288-69-1 |
|---|---|
| Molecular Formula | C6470H10012N1726O2013S42 |
| Molecular Weight | 145531.5 |
| Purity | ≥97% |
| Product Class | Kinase inhibitor |
| Applications | Cancer research |
| Documentation | Certificate of Analysis available on request |
| Manufacturer | TOKU-E |
| MPN | T114 |
| Item number | T114-5MG |
| Pack Size | 5 mg |
| Lead Time | ~7 days |
| Availability | Supplier-sourced |
| Country of Origin | China |
| Storage Temperature | -20°C |
| Shipping Temperature | ambient |
Trastuzumab 5 mg is supplied by Lancetech Limited as an authorised UK distributor for TOKU-E. It is classified as a kinase inhibitor. Typical use: cancer research.
Product details
- CAS number: 180288-69-1
- Molecular formula: C6470H10012N1726O2013S42
- Molecular weight: 145531.5
- Purity: ≥97%
- Pack size: 5 mg
- Storage: -20°C
- Shipping condition: ambient
- Country of origin: China
- Certificate of Analysis available on request
Manufactured by TOKU-E Company, Bellingham, Washington, USA — a specialist producer of antibiotics, antifungals and bioactive small molecules for research and quality control. Supplied in the United Kingdom by Lancetech Limited.
Product documents
Documents are available to registered customers. Sign in or create a free account — it takes a minute.
Shipping & safety
Frequently bought together
More Certified Reference Standards from TOKU-E.
Actinomycin D, 5 mg
Actinomycin D, 10 mg
Actinomycin D, 25 mg
Amikacin 1g
Browse more:TOKU-E Certified Reference StandardsAll TOKU-E productsAll Certified Reference Standards